← All indications
Urinary Tract Infections
Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
Subtype terms (3)
More specific conditions that are subtypes of Urinary Tract Infections in the MeSH hierarchy.
- Bacteriuria
16 drugs (12 approved, 4 experimental)
- Pyuria
1 drug experimental
- Schistosomiasis haematobia
14 drugs (7 approved, 7 experimental)
Drugs by status
Approved for this indication (76)
- levofloxacin
- plazomicin
- avibactam
- aztreonam
- cefazolin
- cefixime
- cefmetazole
- cefotaxime
- cefotetan
- cefoxitin
- cefprozil
- ceftazidime
- cefditoren
- cilastatin
- clavulanate
- cranberry
- d-mannose
- doripenem
- flavoxate
- flucytosine
- fosfomycin
- gepotidacin
- ioxaglic acid
- amoxicillin
- hexamethylenetetramine
- norfloxacin
- phenazopyridine
- pivmecillinam
- prulifloxacin
- methylene blue
- +46 more
Phase 4 trials (42)
- diclofenac
- procaine benzylpenicillin
- conjugated equine estrogens
- ibuprofen
- vitis vinifera
- tamsulosin
- iodine
- vitamin c
- piperacillin
- lactose
- proflavine
- hyaluronic acid
- sulbactam
- temocillin
- estradiol
- cefadroxil
- vancomycin
- xin te mie
- xinzhijun
- atropine
- killed enterotoxigenic escherichia coli vaccine
- escherichia coli nissle 1917
- gentamicin
- azithromycin
- tromethamine
- apricot
- chickpea
- clindamycin
- solifenacin
- cephalexin
- +12 more
Phase 3 trials (30)
- metronidazole
- methylprednisolone
- calcium carbonate
- urea
- bovine lactoferrin
- canephron
- carbavance
- ceftolozane
- eravacycline
- flomoxef
- tigecycline
- heat-inactivated bacteria
- prasterone
- lidocaine
- sitafloxacin
- taniborbactam
- human fecal microbiota
- nacubactam
- pyo phage
- anti-staphylococcus bacteriophage therapy
- lactobacillus crispatus
- quillaja
- probenecid
- colistin
- glucose monohydrate
- tebipenem
- fexapotide
- dexamethasone
- lbp-ec01
- pralurbactam
Phase 2 trials (24)
- vitamin d3
- fluticasone
- heparin
- ceftaroline fosamil
- lurasidone
- 131 iodine
- cycloserine
- finafloxacin
- gsk2251052
- bovine colostrum
- omadacycline
- ozarelix
- cow milk
- pp4001
- sulfur hexafluoride lipid-type a microspheres
- uro vaxom
- degarelix acetate
- amino acids
- uromune
- lactobacillus reuteri
- lys228
- lactobacillus rhamnosus
- allocetra-ots
- lactobacillus delbrueckii
Phase 1 trials (13)
Other trials (29)
- s-methionine
- sucrose
- bacillus clausii
- astragalus membranaceus
- doxycycline
- nitazoxanide
- celecoxib
- bupivacaine
- aronia extract
- bifidobacterium infantis
- boswellia serrata
- lactobacillus plantarum
- lingonberry nectar
- rhizoma atractylodis macrocephalae
- hibiscus sabdariffa
- radix stephaniae tetrandrae
- radix polygoni multiflori
- radix rehmanniae
- radix smilax china
- fructus corni
- rhizoma dioscoreae
- cumin
- temafloxacin
- lactobacillus casei
- fructus schizandrae
- piper cubeba fruit
- tribulus terrestris root
- vaccinium macrocarpon
- rheum emodi
Organizations
Organization Involved with Phase 4 Indications (138)
- Astellas
- Belpharma s.a.
- GlaxoSmithKline
- Mepha Ltd.
- Xiangbei Welman Pharmaceutical Co., Ltd
- Dentsply International
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
- Jhpiego
- Fundação Educacional Serra dos Órgãos
- National Institute of Allergy and Infectious Diseases (NIAID)
- Vastra Gotaland Region
- University of Roma La Sapienza
- Aarhus University
- University of Manitoba
- Medical University of Graz
- Atlantic Health System
- Bronovo Hospital
- Case Western Reserve University
- University of London
- China Academy of Chinese Medical Sciences
- Harvard University
- Dartmouth University
- Duke University
- Gillette Children's Specialty Healthcare
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Katholieke Universiteit Leuven
- Johns Hopkins University
- Mashhad University of Medical Sciences
- Medical Center Haaglanden
- +108 more
Organization Involved with Phase 3 Indications (82)
- Pierre Fabre
- Zavante Therapeutics
- Peninsula Pharmaceuticals
- Achaogen, Inc.
- Takeda
- The Medicines Company
- AstraZeneca
- Novo Nordisk
- Shionogi
- Cubist
- Hamad Medical Corporation
- Inmunotek S.L.
- Sihuan Pharmaceutical Holdings Group Ltd.
- Spero Therapeutics
- Sponsor GmbH
- Tedec-Meiji Farma, S.A.
- VenatoRx Pharmaceuticals, Inc.
- Wockhardt
- Bionorica
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of Pennsylvania
- University of Pittsburgh
- Aligarh Muslim University
- Baylor University
- Federal University of Rio Grande do Sul
- University of Washington
- King George's Medical University
- McGill University
- National Cheng Kung University
- +52 more
Organization Involved with Phase 2 Indications (43)
- Novartis
- Entasis Therapeutics
- MerLion Pharmaceuticals GmbH
- Novexel Inc
- Osel, Inc.
- Paratek Pharmaceuticals Inc
- Westat
- Buckinghamshire Healthcare NHS Trust
- Ain Shams University
- Boston University
- Central Clinical Hospital #1 of LLC Russian Railways
- Kaiser Permanente
- Min-Sheng General Hospital
- Pirogov Russian National Research Medical University
- Queen's University, Belfast
- Russian Academy of Medical Sciences
- Shriners Hospitals for Children
- Justus Liebig University Giessen
- Yale University
- The Christ Hospital
- University of Colorado, Denver
- Hurley Consulting Associates Ltd.
- TriHealth
- Stoke Mandeville Hospital
- Government of Russia
- Pharmaceutical Research Associates, Inc. (PRA)
- Kirov Military Medical Academy
- Pinnacle Pharmaceuticals
- Mississippi Medical Research, LLC
- Pokrovskaya Hospital, St. Petesburg, Russia
- +13 more
Organization Involved with Phase 1 Indications (16)
- GlycoVaxyn
- Tufts University
- Alta Bates Summit Medical Center
- Laval University
- University of California, Irvine
- Jiao Tong University
- American University of Beirut
- Rush University
- Swiss Pharma
- Department of Veteran Affairs
- Nutra Canada
- Taiga BioActives Inc.
- Sage Products, Inc.
- Government of Quebec
- Centers for Disease Control and Prevention (CDC)
- Locus Biosciences
Organization Involved with Other Experimental Indications (31)
- BioGaia AB
- Hamilton Health Sciences Corporation
- myTomorrows
- Swisse Wellness Pty Ltd
- Swedish Institute for Infectious Disease Control
- Region Skane
- Beijing Institute of Disease Control and Prevention
- Tzu Chi University
- Hamdard University
- Lund University
- McMaster University
- Medical University of Warsaw
- Norwegian University of Science and Technology
- Ochsner Health System
- University of Sulaimani
- Uppsala University
- Emek Medical Center
- Karolinska Institute
- University of Texas at Houston
- Vita-Salute University of Milano. Italy
- University of Illinois at Chicago
- Commonwealth Scientific and Industrial Research Organisation, Australia
- Academic Medical Organization of Southwestern Ontario
- Ocean Spray, Inc.
- Government of Norway
- Coloplast A/S
- Hospital General Dr. Manuel Gea Gonzalez
- Theralogix LLC
- Oslo Metropolitan University
- Miralex Sp. z o.o.
- +1 more